Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.67B | 1.03B | -1.07B | 1.50B | 634.43M |
Gross Profit | 1.67B | 1.03B | -1.07B | 1.50B | 634.43M |
EBITDA | 49.70M | 16.40M | -48.40M | 42.19M | 52.04M |
Net Income | 3.90M | 18.70M | -98.33M | 27.29M | 21.19M |
Balance Sheet | |||||
Total Assets | 12.76B | 12.13B | 11.14B | 9.42B | 8.86B |
Cash, Cash Equivalents and Short-Term Investments | 138.00M | 146.00M | 175.29M | 70.09M | 105.35M |
Total Debt | 206.20M | 209.30M | 213.23M | 49.46M | 71.44M |
Total Liabilities | 12.44B | 11.77B | 10.81B | 8.96B | 8.37B |
Stockholders Equity | 314.40M | 359.90M | 333.12M | 458.17M | 487.07M |
Cash Flow | |||||
Free Cash Flow | 37.80M | -35.70M | -80.43M | 20.69M | 49.34M |
Operating Cash Flow | 38.60M | -34.90M | -76.92M | 24.32M | 50.20M |
Investing Cash Flow | 5.00M | 29.50M | 52.05M | -3.64M | 1.88M |
Financing Cash Flow | -49.70M | -49.80M | 127.03M | -49.98M | -59.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | £23.74B | 14.03 | 12.68% | 265.13% | -17.12% | 30.62% | |
67 Neutral | $16.81B | 11.85 | 9.77% | 3.76% | 12.07% | -8.35% | |
67 Neutral | £269.22M | ― | -127.10% | ― | -20.62% | -44.96% | |
62 Neutral | £6.43B | ― | -60.34% | 860.74% | -6.33% | ― | |
62 Neutral | £373.41M | 95.77 | 1.16% | 1258.71% | 22.19% | -79.23% | |
$832.49M | 5.88 | -6.71% | ― | ― | ― | ||
54 Neutral | £69.71M | 43.59 | 8.08% | 705.88% | 35.39% | -76.12% |
Chesnara PLC announced the admission of 79,539,337 new ordinary shares, nil paid, to the London Stock Exchange as part of a Rights Issue. This move is expected to enhance the company’s capital base, potentially improving its market position and providing more opportunities for growth. The Rights Issue aims to strengthen Chesnara’s financial stability, which could have positive implications for stakeholders, including investors and policyholders.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC has announced the publication of a prospectus approved by the FCA for a rights issue intended to raise approximately £140 million. This financial move is expected to strengthen the company’s capital base, potentially enhancing its market position and providing additional resources for strategic growth initiatives.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC has announced its acquisition of HSBC Life (UK) Limited for £260 million, marking a significant expansion in its scale and operations. The acquisition is expected to generate over £800 million in cash over its lifetime, with £140 million in the first five years, and will be funded through internal resources, a revolving credit facility, and a rights issue. This move is anticipated to increase Chesnara’s assets under administration by £4 billion and policies by 454,000, potentially leading to its inclusion in the FTSE 250 index. The acquisition is strategically aligned with Chesnara’s goal of enhancing shareholder value through operating efficiencies, capital synergies, and new business opportunities, reinforcing its position as a leading consolidator in the life and pensions industry.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC has announced its total voting rights, with an issued share capital of 151,124,742 ordinary shares, each carrying one voting right. This information is crucial for shareholders to determine their interests in the company under the FCA’s Disclosure Guidance and Transparency Rules, reflecting Chesnara’s commitment to transparency and regulatory compliance.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC announced that Al Lonie, the Group Chief of Staff and Group Company Secretary, has acquired 56 ordinary shares through a dividend reinvestment plan. This transaction, conducted on the London Stock Exchange, reflects the company’s ongoing commitment to shareholder value and regulatory compliance under the UK Market Abuse Regulation.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc announced that its Group CEO, Steve Murray, has acquired 9,584 ordinary shares through a dividend reinvestment plan. This transaction, conducted on the London Stock Exchange, aligns with the company’s ongoing commitment to shareholder value and regulatory compliance. The acquisition reflects confidence in Chesnara’s strategic direction and its robust market position in the life and pensions sector.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC has announced a change in its board of directors, with Karin Bergstein stepping down and Samantha Tymms being appointed as an Independent Non-Executive Director. Tymms brings extensive experience from global financial services and regulatory bodies, which is expected to support Chesnara’s strategic goals and enhance its board’s capabilities.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £328.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc announced that Tom Howard, Group CFO, and Elsie Murray, associated with the Group CEO, acquired ordinary shares through a dividend reinvestment plan. This move aligns with Chesnara’s strategic focus on shareholder value and reflects confidence in the company’s ongoing operations and market position.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC announced the appointment of Carol Hagh as the new Senior Independent Director, succeeding Jane Dale who retired after a nine-year tenure. This leadership change is expected to leverage Carol’s experience to continue enhancing the company’s governance and strategic direction, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC announced that all resolutions proposed at its 2025 Annual General Meeting were passed with a significant majority. This includes the adoption of audited accounts, approval of the Directors’ Remuneration Report, declaration of a final dividend, and the re-appointment of several directors and auditors. The successful passing of these resolutions reflects strong shareholder support and positions Chesnara to continue its strategic initiatives and maintain its market position.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc announced that Emma Dawe, the newly appointed Group General Counsel, has been granted an award over the company’s ordinary shares under the 2023 Long Term Incentive Plan. This move aligns with the Directors’ Remuneration Policy approved by shareholders and reflects Chesnara’s commitment to strategic leadership. The award, subject to performance targets over three years, underscores the company’s focus on long-term growth and stability, potentially impacting its market positioning positively.
Chesnara PLC has announced its 2025 Annual General Meeting, scheduled for May 13, 2025, at Panmure Liberum’s offices in London. The company encourages electronic voting and pre-submission of questions by shareholders. The preliminary results for 2024 were released on March 27, 2025, proposing a final dividend of 16.08 pence per share. This announcement underscores Chesnara’s commitment to transparency and shareholder engagement, reflecting its ongoing strategic focus on delivering value and maintaining strong financial performance.